Tirofiban for Patients With intraCranial Artery Stenosis and High-risk Acute Non-disabling Cerebrovascular Events(CHANCE-4)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 4674 participants.

Also called NCT06319846

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 4,674 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06319846
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06319846. Randomized; quadruple masking; primary purpose prevention. Start 2024-07-11 (actual); primary completion 2025-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Tirofiban for Patients With intraCranial Artery Stenosis and High-risk Acute Non-disabling Cerebrovascular Events(CHANCE-4)
Condition
Ischemic Stroke, Acute
Condition
Symptomatic Intracranial Artery Stenosis
Intervention (Drug)
Tirofiban
Intervention (Drug)
Placebo
Lead sponsor
Beijing Tiantan Hospital (class: other)

Record details

Record id
cardio:ct-nct06319846
Content hash
c3a2dcf90db26a59307072f9241529cbf8ff28d77abf8be6e2d5ee34a69483e6